Parmax Pharma Limited (BOM:540359)
India · Delayed Price · Currency is INR 132.45
+1.30 (0.99%)
At close: Aug 31, 2026
Parmax Pharma Market Cap
Parmax Pharma has a market cap or net worth of 495.54 million as of September 4, 2026. Its market cap has increased by 273.20% in one year.
Market Cap
495.54M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
132.45
ChartMarket Cap Chart
Since July 26, 2019, Parmax Pharma's market cap has increased from 67.90M to 495.54M, an increase of 629.75%. That is a compound annual growth rate of 32.28%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 31, 2026 | 495.54M | 291.52% |
| Dec 31, 2025 | 126.57M | -23.55% |
| Dec 31, 2024 | 165.55M | 35.86% |
| Dec 29, 2023 | 121.85M | -15.84% |
| Dec 30, 2022 | 144.79M | -35.45% |
| Dec 31, 2021 | 224.29M | 103.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 26, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Source Natural Foods and Herbal Supplements | 685.85M |
| Onyx Biotec | 679.96M |
| Phaarmasia | 563.91M |
| Shelter Pharma | 532.04M |
| Biofil Chemicals and Pharmaceuticals | 515.88M |
| Mangalam Drugs & Organics | 480.39M |
| ANG Lifesciences India | 445.16M |
| Rajnish Wellness | 406.14M |